Guide for Parents: How to help your overweight child
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Larazotide safe, could improve MISC symptoms as adjuvant therapy
“While our study is small, its results are powerful and have implications not only for MIS-C, but potentially for long COVID,” said lead author Lael Yonker, MD.
Food Insecurity and the Dangers of Infant Formula Dilution
Alopecia areata data: Upadacitinib demonstrates improvements in scalp hair coverage
Achieving the primary endpoint, 44.6% and 54.3% of patients treated with upadacitinib (15 mg and 30 mg) reached 80% or more scalp hair coverage.
Demystifying Infant Formula
The Leukemia & Lymphoma Society Unveils Name Change to Reach All Blood Cancer Patients
FDA approves pegcetacoplan as first treatment for C3 glomerulopathy or IC-MPGN
Pegcetacoplan (Empaveli; Apellis Pharmaceuticals) is indicated for patients 12 years or older to reduce proteinuria.